Home >
Medicine Info >
Nebiring 2.5 MG Tablet
Loading interface...

Nebiring 2.5 MG Tablet

Manufactured byOrchid Chemicals & Pharmaceuticals Ltd.
ContainsNebivolol
Description
Nebiring 2.5 MG Tablet is used for the lowering of high blood pressure and relieving chest pain caused due to reduced blood flow to the heart. It is also used for treating other complications associated with heart and blood vessels.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Nebiring 2.5 MG Tablet

Nbp 2.5 MG Tablet
Strides Shasun Ltd.
Nebilong 2.5 MG Tablet
Micro Labs Ltd.
Nebimac 2.5 MG Tablet
Macleods Pharmaceuticals Pvt. Ltd.
Nebistar 2.5 MG Tablet
Lupin Ltd.
Nebula 2.5 MG Tablet
Zydus Cadila

Side effects

Major & minor side effects for Nebiring 2.5 MG Tablet

  • Headache
  • Dizziness
  • Unusual tiredness and weakness
  • Diarrhea
  • Increase in body fat and cholesterol
  • Sleeplessness
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Chest pain and discomfort
  • Decreased blood pressure
  • Difficulty in breathing
  • Weight gain
  • Burning, numbness, tingling in the arms and feet
  • Allergic Skin Reaction

Uses of Nebiring 2.5 MG Tablet

What is it prescribed for?

  • Hypertension
  • Heart Failure
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1-2 hours of administration.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 10-12 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Use of alcohol should be avoided while taking Nebiring 2.5 MG Tablet especially when you start taking the medicine or change the dosage. Symptoms like headache, dizziness, change in pulse or heart rate should be reported to the doctor.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine. Even if the medicine is used, the dose should be as low as possible and should be discontinued at least 2-3 days before delivery.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use by breastfeeding women unless absolutely necessary. The infant should be monitored for adverse effects like changes in pulse rate, respiratory changes, and low blood sugar levels. Consult your doctor before taking this medicine.

Allergy

Nebiring 2.5 MG Tablet is not recommended for people who have a known history of allergy to this medication or any other medicines belonging to the group Beta Blockers. (Eg: Atenolol, Labetalol etc).

Liver disease

Nebiring 2.5 MG Tablet is not recommended for people having a severe liver impairment.

Circulatory disorders

Nebiring 2.5 MG Tablet is not recommended for people suffering from blood circulation disorders or cardiogenic shock.

Heart Failure

Nebiring 2.5 MG Tablet is not recommended for use in people suffering from severe heart failure or people receiving emergency attention.

Heart diseases

Nebiring 2.5 MG Tablet is not recommended for people who have serious heart problems like heart block and Sick Sinus Syndrome, especially if no pacemaker has been implanted to correct the defect.

Bronchial asthma

Nebiring 2.5 MG Tablet is not recommended for use in people having a history of bronchial asthma and bronchospasm or any other condition in which the airway is obstructed.

Heart rhythm disorders

Nebiring 2.5 MG Tablet is not recommended for use in people having heart rhythm disorders like Bradycardia.
Warnings for special population

Pregnancy

This medicine is not recommended for use during pregnancy unless absolutely necessary. Consult your doctor about the potential benefits and risks before deciding to take this medicine. Even if the medicine is used, the dose should be as low as possible and should be discontinued at least 2-3 days before delivery.

Breast-feeding

This medicine is not recommended for use by breastfeeding women unless absolutely necessary. The infant should be monitored for adverse effects like changes in pulse rate, respiratory changes, and low blood sugar levels. Consult your doctor before taking this medicine.
General warnings

Anesthetics

Nebiring 2.5 MG Tablet should be used with caution while a patient is given anesthesia as the risk of adverse effects on the heart and blood circulation is high.

Heart failure

Nebiring 2.5 MG Tablet can cause heart failure and reduced flow of blood especially in people having a heart disease. Suitable dose adjustment and safety monitoring might be required based on the severity of the disease.

Ischemic heart disease

Nebiring 2.5 MG Tablet should not be discontinued abruptly in patients with Ischemic heart disease. The dosage should be gradually reduced over a period of 1 to 2 weeks

Major surgery

Nebiring 2.5 MG Tablet should be given with caution to patients who are going to undergo a major surgery. The dose should be very carefully monitored in such cases both before and after the surgical procedure.

Pheochromocytoma

Nebiring 2.5 MG Tablet should be administered with caution in patients having this condition which results in an excess of substance that controls heart beat, blood pressure etc. Suitable medicine combinations is to be given in order to counter the effects.

Bronchospastic disease

Nebiring 2.5 MG Tablet should be administered with caution in patients having a disease of the lung or the airways leading to the lung. It can be Pneumonia, Asthma or Chronic Obstructive Pulmonary Disease. Suitable dose adjustment and safety monitoring are necessary in such cases.

Diabetes and hypoglycemia

Nebiring 2.5 MG Tablet should be administered with caution in patients having elevated blood sugar levels. Some adverse effects may not be evident in these cases and hence doctor's intervention is a must before taking this medicine.

Thyrotoxicosis

Nebiring 2.5 MG Tablet should be administered with caution in patients having elevated thyroid hormone level. Some adverse effects may not be evident in these cases and hence doctor's intervention is a must before taking this medicine.

Peripheral vascular disease

Nebiring 2.5 MG Tablet should be administered with caution in patients having narrowed blood vessels in the body due to any underlying reason. Dose adjustment and safety monitoring might be required in such cases.

Other medicine

Nebiring 2.5 MG Tablet can react with medicines that you might use. Report the use of all medicines including supplements and herbs to the doctor.

Sports

It is advised to not indulge in certain sports while Nebiring 2.5 MG Tablet is consumed. Archery, racing, shooting and other high-risk sports should be avoided. Sportspersons should refer to the list of medicine published by World Anti-Doping Agency which is not to be taken while participating in specific sports events.

Missed Dose

Take the missed dose as soon as you remember. However, the missed dose can be skipped if it is almost time for the next scheduled dose.

Overdose

An overdose of this medication can cause some serious effects on the heart, blood vessels, and nerve conduction. Report the incidence as soon as possible so that medical intervention can begin. Supportive measures like Gastric lavage and symptomatic treatment might be required based on severity.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Using alcohol while taking Nebiring 2.5 MG Tablet may cause an additional lowering of the blood pressure.

Instructions

Use of alcohol should be avoided while taking Nebiring 2.5 MG Tablet especially when you start taking the medicine or change the dosage. Symptoms like headache, dizziness, change in pulse or heart rate should be reported to the doctor.
Interaction with Medicine

Amlodipine

Diltiazem

Fluoxetine

Amiodarone

Aminophylline

Ergotamine

Disease interactions

Asthma

Nebiring 2.5 MG Tablet should not be used in patients suffering from bronchial asthma or Chronic Obstructive Pulmonary Disease. Report the incidence of Asthma to your doctor so that Nebiring 2.5 MG Tablet can be substituted with another medication.

Heart Block

Nebiring 2.5 MG Tablet should not be used in patients having a heart block greater than first degree. However, it can be used in this case if a pacemaker is present to correct the disorder.

Diabetes

Nebiring 2.5 MG Tablet should be administered with caution in patients suffering from diabetes or a condition where blood sugar level is likely to get low. You should consult a doctor if any symptom indicating a lowered blood sugar level is suspected while using this medicine.

Liver Disease

Nebiring 2.5 MG Tablet should be administered with caution in patients having a liver disease. Suitable dose adjustment and safety monitoring are advised in cases where the impairment is severe.

Glaucoma

Nebiring 2.5 MG Tablet should be administered with caution in a patient suffering from Glaucoma. A change in the dose of current Glaucoma medicine may be required. In some cases, your doctor may advise the use of another medicine in place of a beta blocker.

High cholesterol and fat

Nebiring 2.5 MG Tablet should be administered with caution in a patients having high levels of cholesterol and fat in their body. Suitable dose adjustment and safety monitoring may be required in such cases.

Hyperthyroidism

Nebiring 2.5 MG Tablet should be used with caution in patients having high thyroid hormone levels. Special caution should be taken while withdrawing this medicine. The dosing and effects of the medicine should be closely monitored.

Myasthenia Gravis

Nebiring 2.5 MG Tablet should be used with caution in patients suffering from this condition characterized by severe muscle weakness.

Pheochromocytoma

Nebiring 2.5 MG Tablet should be used with caution in patients suffering from this condition. The treatment should be suitably combined with an alpha-blocker with appropriate dosing and clinical monitoring.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Nebiring 2.5 MG Tablet as instructed by the doctor. The dosage is likely to change based on your response to the medicine. It is advised to take this medicine at the same time of the day. The blood pressure should be monitored at regular intervals to ensure that the response at given dose is appropriate. Do not start or discontinue the usage of any other medication without consulting your doctor.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by relaxing the blood vessels and slowing the heart beat. This results in an improved blood flow to the heart and the blood pressure is lowered.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Cardioselective beta blockers

Schedule

Schedule H

DailyMed - Nebivolol tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 16 November 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f98d499-f68f-4148-8ec3-8c66ef184a83

[Internet]. 2017 [cited 16 November 2017]. Available from:

http://www.medicines.org.uk/emc/medicine/9145

Nebivolol - DrugBank [Internet]. Drugbank.ca. 2017 [cited 16 November 2017]. Available from:

https://www.drugbank.ca/drugs/DB04861
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 16 Nov 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.